IndivuType is a discovery solution by Indivumed -
to support cancer research and development. It enables the discovery of novel insights into the biology of cancer and advances precision oncology.
Customers benefit from unequalled molecular and clinical data quality and state-of-the-art bioinformatics tools to accelerate cancer research and development projects. IndivuType provides data and analytic tools to discover and validate novel molecular drug targets and biomarkers, and simultaneously puts these in a comprehensive biological and clinical context. Capabilities that significantly enhance the probability of success in the clinical phases of drug development.
Unlike conventional, genomics-only approaches, IndivuType draws on a database that integrates multi-omics (genomics, transcriptomics, proteomics, and phosphoproteomics) with clinical and digital pathology data based on the highest quality biospecimens. This provides a better picture and understanding of cancer mechanisms and tumor progression, and ultimately leads to more effective and targeted drugs to treat cancer patients.
The analytical core of IndivuType is an AI-integrated analytics platform named nRavel. It provides an unprecedented ability to investigate and unravel the biology, clinical profile, treatment, and outcome of cancer. Relying on comprehensive bioinformatic and medical knowledge, it leverages the unique and complex datasets contained within the IndivuType database and applies cutting-edge, AI integrated analytical technologies across the oncology informatics spectrum.
With a truly unique asset for making discoveries in oncology, IndivuType can support your specific business needs in a variety of ways. We can either act as a service provider in early oncology research and development or be a trusted development partner for data driven development of novel cancer treatments....
More Info Less Info